Sangamo Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 42 U.S.-traded ETFs. SGMO has around 10.3M shares in the U.S. ETF market. The largest ETF holder of SGMO is the iShares Russell 2000 ETF (IWM), with approximately 2.69M shares. Investors may also find of interest that the ETF with the largest allocation to SGMO stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 1.23%. On average, U.S. ETFs allocate 0.12% of SGMO to their portfolios.
Additionally, SGMO is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SGMO as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 35.39%.